SORRENTO THERAPEUTICS INC (SRNE) Earnings History & Surprises
NASDAQ:SRNE • US83587F2020
0.3073 USD
-0.08 (-20.26%)
At close: Feb 22, 2023
0.2801 USD
-0.03 (-8.85%)
After Hours: 2/22/2023, 8:27:19 PM
Past quarterly earnings results for SORRENTO THERAPEUTICS INC (SRNE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateN/A
PeriodQ4 / 2022
EPS Estimate-$0.23
Revenue Estimate16.905M
Last Reported
Release DateNov 8, 2022
PeriodQ3 / 2022
EPS Reported-$0.20
EPS Surprise 23.11%
Revenue Surprise 25.48%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | -0.20 | -0.26 | 23.11% | 50.00% | 17.4M | 13.867M | 25.48% | 44.25% |
| Q2 2022 | -0.54 | -0.26 | -111.76% | 5.26% | 11.461M | 19.128M | -40.08% | -58.72% |
| Q1 2022 | -0.16 | - | -1,732.00% | 18.385M | 25.52M | -27.96% | 28.57% | |
| Q4 2021 | -0.47 | -0.30 | -56.20% | -74.07% | 13.076M | 15.429M | -15.25% | 13.70% |
| Q3 2021 | -0.40 | -0.23 | -70.50% | -21.21% | 12.062M | 10.383M | 16.17% | 2.22% |
| Q2 2021 | -0.57 | -0.20 | -179.41% | -58.33% | 27.766M | 10.329M | 168.82% | 208.51% |
| Q1 2021 | 0.01 | 0.38 | -97.40% | 104.35% | 14.3M | 17.598M | -18.74% | 85.71% |
| Q4 2020 | -0.27 | 2.77 | -109.75% | - | 11.5M | 1.032B | -98.89% | - |
| Q3 2020 | -0.33 | -0.21 | -57.82% | - | 11.8M | 10.519M | 12.18% | - |
| Q2 2020 | -0.36 | -0.22 | -60.43% | - | 9M | 8.16M | 10.29% | - |
| Q1 2020 | -0.23 | -0.20 | -12.75% | - | 7.7M | 10.2M | -24.51% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-48.29%
Max EPS beat (4)
23.11%
Min EPS beat (4)
-111.77%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-14.45%
Max Revenue beat (4)
25.48%
Min Revenue beat (4)
-40.08%
Analysis
In the last 4 quarters, SRNE has beaten EPS estimates in 1 out of 4 releases
SRNE has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, SRNE reported -48.3% below the EPS estimates on average.
In the last 4 quarters, SRNE reported -14.5% below the revenue estimates on average.
SORRENTO THERAPEUTICS INC / SRNE Earnings FAQ
When did SORRENTO THERAPEUTICS INC (SRNE) report earnings last quarter?
SORRENTO THERAPEUTICS INC (SRNE) last reported earnings on 11/8/2022.
Can you provide information on whether SORRENTO THERAPEUTICS INC beat earnings estimates in the last quarter?
SORRENTO THERAPEUTICS INC (SRNE) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does SRNE stock beat earnings estimates?
In the last 4 quarters, SORRENTO THERAPEUTICS INC (SRNE) has beaten EPS estimates in 1 out of 4 releases.